Meeting
2023 ASCO Quality Care Symposium
Facility type as a prognostic factor? The role of academic centers in outcomes and treatment for patients with leiomyosarcoma.
Authors
Jaikin Patel
Creighton University School of Medicine, Omaha, NE
Jaikin Patel, Marco Braaten, Peter T. Silberstein
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Cancer Outcome Disparities
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 185)
DOI
10.1200/OP.2023.19.11_suppl.185
Abstract #
185
Poster Bd #
E24
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Outcomes of adult urogenital sarcomas: Analysis of surveillance, epidemiology, and end results (SEER) database 2004 to 2015.
First Author: Snigdha Nutalapati
Poster
2013 ASCO Annual Meeting
A large retrospective analysis of trabectedin in 885 patients with advanced soft tissue sarcoma.
First Author: Axel Le Cesne
Poster
2012 ASCO Annual Meeting
Geriatric high-grade soft tissue sarcoma (G-HG STS): An analysis of 116 patients (pts) evaluating prognostic factors and clinical outcomes stratified by histology.
First Author: Richard Hong Hui Quek
Poster
2023 ASCO Quality Care Symposium
Evaluation of delays to multidisciplinary treatment of soft tissue sarcomas at a tertiary cancer center.
First Author: Kelsey B. Montgomery